Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6101
Pacific Biosciences
PACB
$376M
| $1.24M | ﹤0.01% |
904,201
-578,114
| -39% | -$1.17M |
|
6102
Indivior Pharmaceuticals
INDV
$4.61B
| $1.24M | ﹤0.01% |
76,837
-12,558
| -14% | -$227K |
|
6103
PUT
GFL Environmental
GFL
$15.1B
| $1.24M | ﹤0.01% |
31,800
-32,100
| -50% | -$1.1M |
|
6104
PUT
B2Gold
BTG
$6.87B
| $1.24M | ﹤0.01% |
458,500
+107,000
| +30% | +$289K |
|
6105
Levi Strauss
LEVI
$8.68B
| $1.24M | ﹤0.01% |
64,108
-903,878
| -93% | -$19.8M |
|
6106
PUT
Tilray
TLRY
$643M
| $1.24M | ﹤0.01% |
74,410
-45,370
| -38% | -$871K |
|
6107
CALL
Gibraltar Industries
ROCK
$1.42B
| $1.23M | ﹤0.01% |
18,000
+4,400
| +32% | +$320K |
|
|
TIGR
6108
UP Fintech Holding
TIGR
$865M
| $1.23M | ﹤0.01% |
293,644
-34,553
| -11% | -$136K |
|
|
ESGR
6109
DELISTED
Enstar Group
ESGR
| $1.23M | ﹤0.01% |
4,031
-69
| -2% | -$20.7K |
|
6110
CALL
Flowers Foods
FLO
$1.55B
| $1.23M | ﹤0.01% |
55,500
+19,500
| +54% | +$462K |
|
6111
Crane NXT
CXT
$2.97B
| $1.23M | ﹤0.01% |
20,052
-41,839
| -68% | -$2.56M |
|
6112
PUT
Janux Therapeutics
JANX
$994M
| $1.23M | ﹤0.01% |
29,400
-22,600
| -43% | -$1.06M |
|
|
FLNA
6113
PUT
Filana Therapeutics
FLNA
$44.1M
| $1.23M | ﹤0.01% |
99,600
+34,900
| +54% | +$736K |
|
6114
CALL
Steris
STE
$22.7B
| $1.23M | ﹤0.01% |
5,600
-7,500
| -57% | -$1.63M |
|
6115
PUT
Equinox Gold
EQX
$13.8B
| $1.23M | ﹤0.01% |
234,600
-249,600
| -52% | -$1.39M |
|
|
TGNA
6116
PUT
DELISTED
TEGNA Inc
TGNA
| $1.23M | ﹤0.01% |
88,000
+57,800
| +191% | +$815K |
|
6117
NGL Energy Partners
NGL
$2.24B
| $1.23M | ﹤0.01% |
242,334
-92,942
| -28% | -$526K |
|
|
PBT
6118
Permian Basin Royalty Trust
PBT
$1.52B
| $1.23M | ﹤0.01% |
108,811
+42,834
| +65% | +$520K |
|
|
TRTX
6119
CALL
TPG RE Finance Trust
TRTX
$609M
| $1.23M | ﹤0.01% |
141,800
-20,000
| -12% | -$164K |
|
6120
Invesco DB Commodity Index Tracking Fund
DBC
$1.81B
| $1.22M | ﹤0.01% |
52,714
-11,421
| -18% | -$267K |
|
6121
PUT
United States Copper Index Fund
CPER
$750M
| $1.22M | ﹤0.01% |
45,000
-13,600
| -23% | -$382K |
|
6122
AB Core Plus Bond ETF
CPLS
$210M
| $1.22M | ﹤0.01% |
34,883
-2
| -0% | -$70 |
|
6123
PUT
GeneDx Holdings
WGS
$2.33B
| $1.22M | ﹤0.01% |
46,800
+1,600
| +4% | +$30.3K |
|
|
IBIA
6124
DELISTED
iShares iBonds Oct 2024 Term TIPS ETF
IBIA
| $1.22M | ﹤0.01% |
47,774
+19,255
| +68% | +$490K |
|
6125
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.43B
| $1.22M | ﹤0.01% |
18,563
+2,855
| +18% | +$186K |
|
Similar funds
Ken Griffin's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,759 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.
- Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Ken Griffin opened 1,434 new positions and closed 1,759 in Q2 2024.
- Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.